Cite

HARVARD Citation

    Shumilov, E. et al. (n.d.). Osteolytic lesions occur rarely in patients with B-CLL and may respond well to ibrutinib. Leukemia & lymphoma. 57 (10), pp. 2476-2480. [Online]. 
  
Back to record